Invizyne Technologies (NASDAQ:IZTC) Stock Price Down 2% - Here's What Happened

Key Points

• Invizyne Technologies Inc. (NASDAQ:IZTC) saw its stock price fall 2%, closing at $11.76, with trading volume down 97% from the average.
• A hedge fund, BNP Paribas Financial Markets, recently acquired a new stake in the company, purchasing 2,113 shares valued at approximately $35,000.
• Invizyne Technologies specializes in cell-free enzyme-based biomanufacturing, focusing on transforming renewable resources into valuable biochemicals.

Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report)'s share price dropped 2% during mid-day trading on Wednesday . The company traded as low as $11.76 and last traded at $11.76. Approximately 1,088 shares changed hands during trading, a decline of 97% from the average daily volume of 37,647 shares. The stock had previously closed at $12.00.

Invizyne Technologies Stock Performance

The stock's 50 day moving average is $10.12 and its 200-day moving average is $11.69.

Hedge Funds Weigh In On Invizyne Technologies

A hedge fund recently bought a new stake in Invizyne Technologies stock. BNP Paribas Financial Markets bought a new stake in shares of Invizyne Technologies Inc. (NASDAQ:IZTC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,113 shares of the company's stock, valued at approximately $35,000.

Invizyne Technologies Company Profile

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.